SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
Summary: CellMiner-SCLC (https://discover.nci.nih.gov/SclcCellMinerCDB/) integrates drug sensitivity and genomic data, including high-resolution methylome and transcriptome from 118 patient-derived small cell lung cancer (SCLC) cell lines, providing a resource for research into this “recalcitrant ca...
Main Authors: | Camille Tlemsani, Lorinc Pongor, Fathi Elloumi, Luc Girard, Kenneth E. Huffman, Nitin Roper, Sudhir Varma, Augustin Luna, Vinodh N. Rajapakse, Robin Sebastian, Kurt W. Kohn, Julia Krushkal, Mirit I. Aladjem, Beverly A. Teicher, Paul S. Meltzer, William C. Reinhold, John D. Minna, Anish Thomas, Yves Pommier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124720312857 |
Similar Items
-
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
by: Alberto Ballestrero, et al.
Published: (2017-10-01) -
Schlafens: Emerging Proteins in Cancer Cell Biology
by: Sarmad Al-Marsoummi, et al.
Published: (2021-08-01) -
Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
by: Ukhyun Jo, et al.
Published: (2021-09-01) -
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses
by: Erik H. Knelson, et al.
Published: (2021-02-01) -
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors
by: Sukhbir Kaur, et al.
Published: (2019-10-01)